Benzinga | Nov 24, 2021 07:35AM EST

Wells Fargo Maintains Overweight on Medtronic, Lowers Price Target to $137

Wells Fargo analyst Larry Biegelsen maintains Medtronic (NYSE:MDT) with a Overweight and lowers the price target from $144 to $137.